4ncg: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Discovery of Doravirine, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses== | ==Discovery of Doravirine, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses== | ||
<StructureSection load='4ncg' size='340' side='right' caption='[[4ncg]], [[Resolution|resolution]] 2.58Å' scene=''> | <StructureSection load='4ncg' size='340' side='right'caption='[[4ncg]], [[Resolution|resolution]] 2.58Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4ncg]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Hiv-1 Hiv-1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NCG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4NCG FirstGlance]. <br> | <table><tr><td colspan='2'>[[4ncg]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Hiv-1 Hiv-1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NCG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4NCG FirstGlance]. <br> | ||
| Line 26: | Line 26: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Hiv-1]] | [[Category: Hiv-1]] | ||
[[Category: Large Structures]] | |||
[[Category: Yan, Y]] | [[Category: Yan, Y]] | ||
[[Category: Hiv-1 reverse transcriptase]] | [[Category: Hiv-1 reverse transcriptase]] | ||
